Results
1 -
10 of
63Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzae, Journal of Infection and Chemotherapy In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis, Journal of Infection and Chemotherapy Garenoxacin-induced increase of CD11b expression on human polymorphonuclear neutrophils does not affect phagocytosis and killing of Staphylococcus aureus, Journal of Infection and Chemotherapy Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice, Clinical and Experimental Nephrology Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan, Journal of Infection and Chemotherapy Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats, Archives of Toxicology Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats, Archives of Toxicology Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats, Journal of Infection and Chemotherapy Children as a special population at risk ? quinolones as an example for xenobiotics exhibiting skeletal toxicity, Archives of Toxicology Fluoroquinolones in the treatment of meningitis, Current Infectious Disease Reports